Latifnia, M (2020) The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology.
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Saeed Shoja |
| Date Deposited: | 09 Apr 2020 17:05 |
| Last Modified: | 09 Apr 2020 17:05 |
| URI: | http://eprints.medsab.ac.ir/id/eprint/1439 |
Actions (login required)
 |
View Item |
